H
Hakon Hakonarsen
Researcher at University of Pennsylvania
Publications - 2
Citations - 285
Hakon Hakonarsen is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Progressive supranuclear palsy & Corticobasal degeneration. The author has an hindex of 2, co-authored 2 publications receiving 246 citations.
Papers
More filters
Journal ArticleDOI
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
Naomi Kouri,Owen A. Ross,Beth A. Dombroski,Curtis S. Younkin,Daniel J. Serie,Alexandra I. Soto-Ortolaza,Matthew C. Baker,Ni Cole A. Finch,Hyejin Yoon,Jungsu Kim,Shinsuke Fujioka,Catriona McLean,Bernardino Ghetti,Salvatore Spina,Laura B. Cantwell,Martin R. Farlow,Jordan Grafman,Edward D. Huey,Mi Ryung Han,Sherry Beecher,Evan T. Geller,Hans A. Kretzschmar,Sigrun Roeber,Marla Gearing,Jorge L. Juncos,Jean Paul Vonsattel,Vivianna M. Van Deerlin,Murray Grossman,Howard I. Hurtig,Rachel Goldmann Gross,Steven E. Arnold,John Q. Trojanowski,Virginia M.-Y. Lee,Gregor K. Wenning,Charles L. White,Günter U. Höglinger,Günter U. Höglinger,Günter U. Höglinger,Ulrich Müller,Bernie Devlin,Lawrence I. Golbe,Julia E. Crook,Joseph E. Parisi,Bradley F. Boeve,Keith A. Josephs,Zbigniew K. Wszolek,Ryan J. Uitti,Neill R. Graff-Radford,Irene Litvan,Steven G. Younkin,Li-San Wang,Nilufer Ertekin-Taner,Rosa Rademakers,Hakon Hakonarsen,Gerard D. Schellenberg,Dennis W. Dickson +55 more
TL;DR: A genome-wide association study (GWAS) in CBD cases (n=152) and 3,311 controls, and 67 CBD cases and 439 controls in a replication stage was conducted in this article.
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
Naomi Kouri,Owen A. Ross,Beth A. Dombroski,Curtis S. Younkin,Daniel J. Serie,Alexandra I. Soto-Ortolaza,Matthew C. Baker,Ni Cole A. Finch,Hyejin Yoon,Jungsu Kim,Shinsuke Fujioka,Catriona McLean,Bernardino Ghetti,Salvatore Spina,Laura B. Cantwell,Martin R. Farlow,Jordan Grafman,Edward D. Huey,Mi Ryung Han,Sherry Beecher,Evan T. Geller,Hans A. Kretzschmar,Sigrun Roeber,Marla Gearing,Jorge L. Juncos,Jean Paul Vonsattel,Vivianna M. Van Deerlin,Murray Grossman,Howard I. Hurtig,Rachel Goldmann Gross,Steven E. Arnold,John Q. Trojanowski,Virginia M.-Y. Lee,Gregor K. Wenning,Charles L. White,Günter U. Höglinger,Günter U. Höglinger,Günter U. Höglinger,Ulrich Müller,Bernie Devlin,Lawrence I. Golbe,Julia E. Crook,Joseph E. Parisi,Bradley F. Boeve,Keith A. Josephs,Zbigniew K. Wszolek,Ryan J. Uitti,Neill R. Graff-Radford,Irene Litvan,Steven G. Younkin,Li-San Wang,Nilufer Ertekin-Taner,Rosa Rademakers,Hakon Hakonarsen,Gerard D. Schellenberg,Dennis W. Dickson +55 more
TL;DR: A genome-wide association study in CBD cases and controls shows that CBD and PSP share a genetic risk factor other than MAPT at 3p22 MOBP (myelin-associated oligodendrocyte basic protein).